-
BioSense became residents of JLABS@Shanghai
| Press Release
BioSense is among the first 31 companies who were handpicked by Johnson & Johnson Innovation to become residents of JLABS@Shanghai, the largest JLABS in its global network. JLABS@Shanghai opened its door to support scientific entrepreneurs in China and Asia and held its Grand Opening on June 27, 2019 in Shanghai at the Shanghai Tower. BioSense CEO, Andy Li, gave a company presentation to introduce BioSense Suzhou Ltd. at the Grand Opening. Read more about JABS@Shanghai here. Read more about the Grand Opening in Chinese…
-
BioSense Global and Rexahn Announce Collaboration and License Agreement for RX-3117 in Greater China
| Press Release
BioSense Global and Rexahn collaborate and sign License Agreement to advance the development and commercialization of RX-3117 for pancreatic cancer and other cancers in Greater China. Read more here.
-
BioSense Global CEO moderates panel discussion at BIO Europe Spring in Vienna
| Communications
BioSense Global CEO, Andy Li, is invited as a moderator to lead a panel discussion at the 2019 BIO Europe Spring Conference on March 25th, 2019 in Vienna. At the event Mr. Li and his fellow panelists Dong Chen, Katherine Cohen and Olivier Rainhard will explore and explain the opportunity and challenge for cross-border transactions and collaborations between China and Europe. Read more details in Chinese language here.
